Conditional survival for longer-term survivors from 2000-2004 using population-based cancer registry data in Osaka, Japan

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Ito, Yuri ^a   Nakayama, Tomio ^a   Miyashiro, Isao ^a   Ioka, Akiko ^a   Tsukuma, Hideaki ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

Cancer registries; Conditional survival; Japan; Relative survival

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER REGISTRY; CANCER SURVIVAL; CANCER SURVIVOR; COLORECTAL CANCER; FEMALE; FOLLOW UP; HUMAN; JAPAN; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PROSTATE CANCER; STOMACH CANCER; AGE DISTRIBUTION; CANCER STAGING; MIDDLE AGED; MORTALITY; NEOPLASM; PATHOLOGY; REGISTER; STATISTICS AND NUMERICAL DATA; SURVIVAL; SURVIVOR; YOUNG ADULT;

ADULT; AGE DISTRIBUTION; AGED; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; REGISTRIES; SURVIVAL ANALYSIS; SURVIVORS; YOUNG ADULT;

EID: 84879079874     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-304     Document Type: Article

References (27)

1. National Research Council 2 Cancer Survivors. From Cancer Patient to Cancer Survivor: Lost in Transition 2005, 23-65. Washington D.C.: The National Academies Press, Hewitt M, Greenfield S, Stovall E, National Research Council.
2. Yu XQ, Baade PD, O'Connell DL. Conditional survival of cancer patients: an Australian perspective. BMC Cancer 2012, 12:460. 10.1186/1471-2407-12-460, 3519618, 23043308.
3. Allemani C, Minicozzi P, Berrino F, Bastiaannet E, Gavin A, Galceran J, Ameijide A, Siesling S, Mangone L, Ardanaz E, et al. Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002. Int J Cancer 2013, 132(10):2404-2412. 10.1002/ijc.27895, 23047687.
4. Abbott AM, Habermann EB, Parsons HM, Tuttle T, Al-Refaie W. Prognosis for primary retroperitoneal sarcoma survivors: a conditional survival analysis. Cancer 2012, 118(13):3321-3329. 10.1002/cncr.26665, 22246900.
5. Ellison LF, Bryant H, Lockwood G, Shack L. Conditional survival analyses across cancer sites. Health Rep 2011, 22(2):21-25.
6. Baade PD, Youlden DR, Chambers SK. When do I know I am cured? Using conditional estimates to provide better information about cancer survival prospects. Med J Aust 2011, 194(2):73-77.
7. Xing Y, Chang GJ, Hu CY, Askew RL, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Lucci A, Cormier JN. Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysis. Cancer 2010, 116(9):2234-2241. 2860044, 20187100.
8. Merrill RM, Hunter BD. Conditional survival among cancer patients in the United States. Oncologist 2010, 15(8):873-882. 10.1634/theoncologist.2009-0211, 3228022, 20647391.
9. Janssen-Heijnen ML, Houterman S, Lemmens VE, Brenner H, Steyerberg EW, Coebergh JW. Prognosis for long-term survivors of cancer. Ann Oncol 2007, 18(8):1408-1413. 10.1093/annonc/mdm127, 17693654.
10. Skuladottir H, Olsen JH. Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark. J Clin Oncol 2003, 21(16):3035-3040. 10.1200/JCO.2003.04.521, 12915592.
11. Bryant H, Lockwood G, Rahal R, Ellison L. Conditional survival in Canada: adjusting patient prognosis over time. Current oncol (Toronto Ont) 2012, 19(4):222-224.
12. The Basic Plan to Promote Cancer Control Programmes in Japan http://www.mhlw.go.jp/shingi/2007/06/dl/s0615-1a.pdf [in Japanese].
13. World Health Organization International Classification of Diseases, 10th revision World Health Organization.
14. Berkson J, Gage R. Calculation of survival rates for cancer. Proceed Staff Meeting Mayo Clinic 1950, 25:270-286.
15. Esteve J, Benhamou E, Croasdale M, Raymond L. Relative survival and the estimation of net survival: elements for further discussion. Stat Med 1990, 9(5):529-538. 10.1002/sim.4780090506, 2349404.
16. Cancer Research UK Cancer Survival Group, London School of Hygiene and Tropical Medicine strel computer program version 1.2.7 for cancer survival analysis 2009, Cancer Research UK Cancer Survival Group, London School of Hygiene and Tropical Medicine.
17. Abridged life tables in Japan for 1962-2011 http://ganjoho.jp/professional/statistics/cohort01.html [in Japanese].
18. Brenner H, Gefeller O. Deriving more up-to-date estimates of long-term patient survival. J Clin Epidemiol 1997, 50(2):211-216. 10.1016/S0895-4356(97)00280-1, 9120515.
19. Rubin DB. Multiple Imputation for Nonresponse in Surveys 1987, New York: John Wiley & Sons.
20. StataCorp Stata Statistical Software: Release 12. College Station 2011, TX: StataCorp LP, StataCorp.
21. Verdecchia A, De Angelis R, Capocaccia R, Sant M, Micheli A, Gatta G, Berrino F. The cure for colon cancer: results from the EUROCARE study. Int J Cancer 1998, 77(3):322-329. 10.1002/(SICI)1097-0215(19980729)77:3<322::AID-IJC2>3.0.CO;2-Q, 9663589.
22. Lambert PC, Thompson JR, Weston CL, Dickman PW. Estimating and modeling the cure fraction in population-based cancer survival analysis. Biostatistics 2007, 8(3):576-594.
23. Isobe Y, Nashimoto A, Akazawa K, Oda I, Hayashi K, Miyashiro I, Katai H, Tsujitani S, Kodera Y, Seto Y, et al. Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry. Gastric cancer official j Int Gastric Cancer Association Japanese Gastric Cancer Association 2011, 14(4):301-316.
24. Hamashima C, Shibuya D, Yamazaki H, Inoue K, Fukao A, Saito H, Sobue T. The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol 2008, 38(4):259-267. 10.1093/jjco/hyn017, 18344316.
25. Toyoda Y, Nakayama T, Ioka A, Tsukuma H. Trends in lung cancer incidence by histological type in Osaka. Japan Jpn J Clin Oncol 2008, 38(8):534-539.
26. Devesa SS, Bray F, Vizcaino AP, Parkin DM. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005, 117(2):294-299. 10.1002/ijc.21183, 15900604.
27. de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012, 13(6):607-615. 10.1016/S1470-2045(12)70137-7, 22575588.